Uranium Energy’s Operational Leap Meets a Test of Nerves on Wall Street

Uranium Energy begins production at Hobson plant, sells unhedged uranium at a premium, but stock faces 32% drawdown and 79% annualized volatility.

Uranium Energy has started up the first new in-situ recovery uranium mine in the United States in over a decade, yet its stock remains a wild ride that has left many holders nursing a 32% drawdown from the year’s high. The company’s progress on the ground and its aggressive, unhedged sales strategy are increasingly at odds with the mood in the trading pits.

The Hobson Central Processing Plant in Texas is now processing ore from the Burke Hollow project, a milestone that positions Uranium Energy as a rare domestic producer. The plant is licensed to handle up to 4 million pounds of U3O8 annually. In Wyoming, the Christensen Ranch facility has received regulatory approval for three additional header houses after its ramp-up had fallen behind schedule. Looking ahead, the company targets 2027 for the start of the Ludeman ISR project.

That operational progress is underpinned by a pricing approach that few peers dare to follow. Uranium Energy sells all its production without hedging, exposing it to spot-market swings but also allowing it to capture outsized gains when prices spike. In the most recent quarter, the company fetched $101 per pound of uranium – a full $20 premium over the average spot price of $80.76 during the same period. Sales of 200,000 pounds from its physical portfolio generated $20.2 million in quarterly revenue and a $10 million gross profit.

The bottom line, however, showed a net loss of roughly $14 million, driven by elevated development and operational costs. For a company scaling up production from scratch, that is part of the script rather than a red flag. Management also has ample firepower: $486 million in cash, zero debt, and total liquidity of $818 million.

On the trading side, the stock has been anything but steady. After touching a 12-month gain of over 150%, the shares have pulled back sharply. At the last check in New York, Uranium Energy closed at $13.10, up 2.75% on the session, following an earlier dip to $12.55 before buyers stepped in. The rebound came after a volatile stretch that included a 9.77% drop and a subsequent 7.05% gain. On a euro basis, the stock finished the week at €11.24. Over the trailing 30 days, the stock is down about 14% in dollar terms, and the annualized 30-day volatility sits at nearly 79% – a figure that keeps the name off most conservative watchlists.

The uranium spot price provides a partial tailwind. The spot market rose to $86.25 per pound in April, while TradeTech’s long-term price indicator stood at $93 at the end of the month. That backdrop matters for Uranium Energy, because the company’s share price is tightly coupled to sector sentiment and expectations around nuclear fuel supply security.

Short sellers are adding another layer of intensity. At the end of April, 58.6 million shares were sold short, representing 12.19% of the float. The days-to-cover ratio of 6.2 means that any sustained rally could force a squeeze, while a loss of momentum could quickly attract renewed bearish pressure. The short interest rose by just 0.20% from the previous period, but the absolute level remains elevated, helping explain the stock’s violent swings in both directions.

On the technical side, the $13 level is an immediate line in the sand. Holding that zone keeps the door open for a move toward the prior reference point near $14.94. A breakdown below $12.55 would significantly damage the recent rebound signal. The relative strength index at 45.4 suggests the stock is neither overbought nor oversold, leaving room for further movement either way.

H.C. Wainwright maintains a buy rating with a $26.75 price target, pointing to structural supply deficits in the U.S. uranium market. Whether the stock ever reaches that level will depend on how quickly Burke Hollow and Christensen Ranch can hit planned production rates – and whether the uranium price can shake off its recent softness long enough to justify the premium valuation embedded in that target.